Trial Details
UNKNOWNBasic Information
| Clinical ID | c3450 |
|---|---|
| Identifier | NCT02044952 |
| Trial Title | Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Crohn's Disease|Gastrointestinal Diseases|Digestive System Diseases|Intestinal Diseases |
| Interventions | DRUG: Mesalazine, Tripterygium glycosides |
Participant Information
| Sponsor | Zhu Weiming |
|---|---|
| City | Nanjing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2014-01 |
|---|---|
| Primary Completion Date | 2016-05 |
| Completion Date | 2016-07 |